ARCHIVES

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

This article is from The Cancer Letter archive.

Vol. 11 No. 32 | August 9, 1985

Download PDF Visit The Full Archive

Related Articles

Panitumumab Improves PFS In Metastatic Colon Cancer

April 28, 2006

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

September 15, 2006

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011